Literature DB >> 15964954

Antibody reactivity to linear epitopes of Plasmodium falciparum cytoadherence-linked asexual gene 9 in asymptomatic children and adults from papua new Guinea.

Katharine R Trenholme1, Craig S Boutlis, Rachel Kuns, Moses Lagog, Moses J Bockarie, Michelle L Gatton, David J Kemp, Michael F Good, Nicholas M Anstey, Donald L Gardiner.   

Abstract

The cytoadherence-linked asexual gene 9 (clag 9) of Plasmodium falciparum has been implicated in the cytoadherence of infected erythrocytes. To determine the immunogenicity of the clag 9 gene product (CLAG 9 protein) in humans, we measured antibody responses to 11 synthetic CLAG 9 peptides in a group of 177 asymptomatic children and adults subject to intense malaria exposure in Madang, Papua New Guinea. The CLAG 9 peptides were immunogenic in adults and children. Antibody responses to peptides 4 and 10 were high across all age groups and detectable in a majority of children less than five years of age. While CLAG 9 peptides are immunogenic in humans, longitudinal studies will be required to determine the longevity of antibody responses to CLAG 9 and their role in protection from disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964954      PMCID: PMC2532502     

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  37 in total

1.  The sequence of clag 9, a subtelomeric gene of plasmodium falciparum is highly conserved.

Authors:  J A Manski-Nankervis; D L Gardiner; P Hawthorne; D C Holt; M Edwards; D J Kemp; K R Trenholme
Journal:  Mol Biochem Parasitol       Date:  2000-12       Impact factor: 1.759

2.  Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum.

Authors:  D M Okenu; E M Riley; Q D Bickle; P U Agomo; A Barbosa; J R Daugherty; D E Lanar; D J Conway
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Gamma-globulin and acquired immunity to human malaria.

Authors:  S COHEN; I A McGREGOR; S CARRINGTON
Journal:  Nature       Date:  1961-11-25       Impact factor: 49.962

4.  Inhibition of Plasmodium falciparum clag9 gene function by antisense RNA.

Authors:  D L Gardiner; D C Holt; E A Thomas; D J Kemp; K R Trenholme
Journal:  Mol Biochem Parasitol       Date:  2000-09       Impact factor: 1.759

5.  Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria.

Authors:  J D Smith; A G Craig; N Kriek; D Hudson-Taylor; S Kyes; T Fagan; T Fagen; R Pinches; D I Baruch; C I Newbold; L H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

6.  What does a single determination of malaria parasite density mean? A longitudinal survey in Mali.

Authors:  V Delley; P Bouvier; N Breslow; O Doumbo; I Sagara; M Diakite; A Mauris; A Dolo; A Rougemont
Journal:  Trop Med Int Health       Date:  2000-06       Impact factor: 2.622

7.  Cytoadhesion of Plasmodium falciparum ring-stage-infected erythrocytes.

Authors:  B Pouvelle; P A Buffet; C Lépolard; A Scherf; J Gysin
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

8.  Age- and species-specific duration of infection in asymptomatic malaria infections in Papua New Guinea.

Authors:  M C Bruce; C A Donnelly; M Packer; M Lagog; N Gibson; A Narara; D Walliker; M P Alpers; K P Day
Journal:  Parasitology       Date:  2000-09       Impact factor: 3.234

9.  Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses.

Authors:  V Fernandez; M Hommel; Q Chen; P Hagblom; M Wahlgren
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

10.  clag9: A cytoadherence gene in Plasmodium falciparum essential for binding of parasitized erythrocytes to CD36.

Authors:  K R Trenholme; D L Gardiner; D C Holt; E A Thomas; A F Cowman; D J Kemp
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

View more
  7 in total

1.  French Haemovigilance Data on Platelet Transfusion.

Authors:  Béatrice Willaert; Mai-Phuong Vo Mai; Cyril Caldani
Journal:  Transfus Med Hemother       Date:  2008-03-19       Impact factor: 3.747

2.  Malaria.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

3.  Malaria.

Authors:  Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Bernd Jansen; Horst Klamm; Wolf-Dieter Ludwig; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Hannelore Willkommen; Karl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2008-03-17       Impact factor: 3.747

4.  Specific antibody responses against membrane proteins of erythrocytes infected by Plasmodium falciparum of individuals briefly exposed to malaria.

Authors:  Albin Fontaine; Matthieu Pophillat; Stéphanie Bourdon; Claude Villard; Maya Belghazi; Patrick Fourquet; Claude Durand; Didier Lefranc; Christophe Rogier; Thierry Fusai; Lionel Almeras
Journal:  Malar J       Date:  2010-10-11       Impact factor: 2.979

5.  Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax.

Authors:  Joana D'Arc Neves Costa; Fernando Berton Zanchi; Francisco Lurdevanhe da Silva Rodrigues; Eduardo Rezende Honda; Tony Hiroschi Katsuragawa; Dhélio Batista Pereira; Roger Lafontaine Mesquita Taborda; Mauro Shugiro Tada; Ricardo de Godoi Mattos Ferreira; Luiz Hildebrando Pereira-da-Silva
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-02       Impact factor: 2.743

Review 6.  The role played by alternative splicing in antigenic variability in human endo-parasites.

Authors:  Rodney Hull; Zodwa Dlamini
Journal:  Parasit Vectors       Date:  2014-01-28       Impact factor: 3.876

Review 7.  [Malaria. Statements of the Blood Work Group of the Federal Health Ministry].

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2008-02       Impact factor: 1.513

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.